QIAGEN Receives U.S. Clearance for QIAsymphony RGQ MDx System and Diagnostic Workflow for C. difficile

[PR Newswire] – FDA clearance for QIAsymphony RGQ MDx, a complete sample-to-result automation platform, marks a milestone for one of QIAGEN’s major global growth drivers U.S. launch of artus C. difficile QS-RGQ MDx Kit will provide a reliable molecular t more

View todays social media effects on QGEN

View the latest stocks trending across Twitter. Click to view dashboard

See who Qiagen is hiring next, click here to view